1 option
Innovation and Health Inequality: Evidence from Direct-Acting Antivirals / Kevin Callison, Michael E. Darden, Keith F. Teltser.
- Format:
- Book
- Author/Creator:
- Callison, Kevin.
- Series:
- Working Paper Series (National Bureau of Economic Research) no. w33735.
- NBER working paper series no. w33735
- Language:
- English
- Physical Description:
- 1 online resource: illustrations (black and white);
- Place of Publication:
- Cambridge, Mass. National Bureau of Economic Research 2025.
- Summary:
- We study disparities in liver transplant allocation when innovation alleviates the scarcity of organs. When direct-acting antivirals for Hepatitis C (HCV) reduced HCV+ liver demand, we show a disproportionate increase in White HCV- liver transplants (56.6%) relative to Black HCV- transplants (11.9%). The time to transplant decreased (31.1%), and the transplant rate increased (19.5pp), only for White HCV- patients. Our results are surprising because liver health is the primary determinant of transplant priority and marginal White patients were of better liver health. We show more similar gains when we focus on privately insured patients and/or areas with more Black patients.
- Notes:
- May 2025.
- Print version record
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.